NOD1 ligand FK565 promotes atherogenesis and accumulation of NOD1+ smooth muscle cells in atherosclerotic lesions

Atherosclerosis · Published 2026-05-24 · DOI 10.1016/j.atherosclerosis.2026.120729

Free full text

Authors (10)

Xiao-Ying Zhang, Xin-Tong Jiang, Anton Gisterå, Yanchun Ding, Layth Basbous, Peder S. Olofsson, Piotr Religa, Göran K. Hansson, Zhong-Qun Yan, Maria E. Johansson

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Zhang, X., Jiang, X., Gisterå, A., et al. (2026). NOD1 ligand FK565 promotes atherogenesis and accumulation of NOD1+ smooth muscle cells in atherosclerotic lesions. Atherosclerosis. https://doi.org/10.1016/j.atherosclerosis.2026.120729

Related articles

• Persistent gaps in management and risk factor control among patients with atherosclerotic cardiovascular disease: All of us research program · Atherosclerosis · 2026 · Same journal
• Standard modifiable cardiovascular risk factors and acute coronary syndrome free survival · Atherosclerosis · 2026 · Same journal
• Lipid profile in pediatric and adult patients with lysosomal acid lipase deficiency treated with sebelipase alfa: longitudinal evidence from the International LAL-D Registry · Atherosclerosis · 2026 · Same journal
• CD146 extracellular vesicles accumulate at atherosclerotic lesions, reducing inflammation and atheroma burden · Atherosclerosis · 2026 · Same journal
• Precision and network medicine in cardiovascular prevention and disease · Atherosclerosis · 2026 · Same journal
• Dietary vitamin K intakes and atherosclerotic cardiovascular disease incidence: Findings from the UK biobank · Atherosclerosis · 2026 · Same journal
• Serial OCT-based coronary physiology and plaque composition in vessels with nonobstructive coronary lesions following intensive lipid-lowering therapy: YELLOW III sub-study · Atherosclerosis · 2026 · Same journal
• Culprit in custody but disease remains at large: OCT substrate and the residual SYNTAX score · Atherosclerosis · 2026 · Same journal
• Elevated remnant cholesterol, but not LDL cholesterol, explains part of recurrent ASCVD events in individuals with and without impaired renal function: the Copenhagen General Population Study and the UK Biobank · Atherosclerosis · 2026 · Same journal
• Methodological and clinical considerations in a Japanese cohort study of familial hypercholesterolemia and stroke—authors’ reply · Atherosclerosis · 2026 · Same journal